KR101666505B1 - 신규한 삼차 8-히드록시퀴놀린-7-카르복사미드 유도체 및 이의 용도 - Google Patents

신규한 삼차 8-히드록시퀴놀린-7-카르복사미드 유도체 및 이의 용도 Download PDF

Info

Publication number
KR101666505B1
KR101666505B1 KR1020127019421A KR20127019421A KR101666505B1 KR 101666505 B1 KR101666505 B1 KR 101666505B1 KR 1020127019421 A KR1020127019421 A KR 1020127019421A KR 20127019421 A KR20127019421 A KR 20127019421A KR 101666505 B1 KR101666505 B1 KR 101666505B1
Authority
KR
South Korea
Prior art keywords
methanone
hydroxyquinolin
hydroxy
carboxamide
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020127019421A
Other languages
English (en)
Korean (ko)
Other versions
KR20120101563A (ko
Inventor
스테파니아 가그리아르디
소르도 시모네 델
페데리코 메일랜드
미켈라 레고라
Original Assignee
폴리켐 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42026678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101666505(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 폴리켐 에스.에이. filed Critical 폴리켐 에스.에이.
Publication of KR20120101563A publication Critical patent/KR20120101563A/ko
Application granted granted Critical
Publication of KR101666505B1 publication Critical patent/KR101666505B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020127019421A 2009-12-29 2010-12-28 신규한 삼차 8-히드록시퀴놀린-7-카르복사미드 유도체 및 이의 용도 Expired - Fee Related KR101666505B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09180902.0 2009-12-29
EP09180902A EP2345643A1 (en) 2009-12-29 2009-12-29 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
PCT/EP2010/070790 WO2011080264A1 (en) 2009-12-29 2010-12-28 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof

Publications (2)

Publication Number Publication Date
KR20120101563A KR20120101563A (ko) 2012-09-13
KR101666505B1 true KR101666505B1 (ko) 2016-10-14

Family

ID=42026678

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127019421A Expired - Fee Related KR101666505B1 (ko) 2009-12-29 2010-12-28 신규한 삼차 8-히드록시퀴놀린-7-카르복사미드 유도체 및 이의 용도

Country Status (37)

Country Link
US (1) US8729098B2 (cg-RX-API-DMAC7.html)
EP (2) EP2345643A1 (cg-RX-API-DMAC7.html)
JP (1) JP5808754B2 (cg-RX-API-DMAC7.html)
KR (1) KR101666505B1 (cg-RX-API-DMAC7.html)
CN (2) CN102686566A (cg-RX-API-DMAC7.html)
AU (1) AU2010338267B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012015728A2 (cg-RX-API-DMAC7.html)
CA (1) CA2783213C (cg-RX-API-DMAC7.html)
CL (1) CL2012001757A1 (cg-RX-API-DMAC7.html)
CY (1) CY1116493T1 (cg-RX-API-DMAC7.html)
DK (1) DK2519505T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2012000186A (cg-RX-API-DMAC7.html)
EA (1) EA025563B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP12012007A (cg-RX-API-DMAC7.html)
ES (1) ES2540327T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20156244B (cg-RX-API-DMAC7.html)
GT (1) GT201200216A (cg-RX-API-DMAC7.html)
HR (1) HRP20150749T1 (cg-RX-API-DMAC7.html)
HU (1) HUE027220T2 (cg-RX-API-DMAC7.html)
IL (1) IL220427A (cg-RX-API-DMAC7.html)
MA (1) MA33829B1 (cg-RX-API-DMAC7.html)
MX (1) MX2012007748A (cg-RX-API-DMAC7.html)
MY (1) MY161869A (cg-RX-API-DMAC7.html)
NI (1) NI201200114A (cg-RX-API-DMAC7.html)
NZ (1) NZ600788A (cg-RX-API-DMAC7.html)
PE (1) PE20130179A1 (cg-RX-API-DMAC7.html)
PH (1) PH12012501326A1 (cg-RX-API-DMAC7.html)
PL (1) PL2519505T3 (cg-RX-API-DMAC7.html)
PT (1) PT2519505E (cg-RX-API-DMAC7.html)
RS (1) RS54096B1 (cg-RX-API-DMAC7.html)
SG (1) SG181586A1 (cg-RX-API-DMAC7.html)
SI (1) SI2519505T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201500182B (cg-RX-API-DMAC7.html)
TN (1) TN2012000320A1 (cg-RX-API-DMAC7.html)
UA (1) UA107949C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011080264A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201204347B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
CN104185624B (zh) * 2012-02-24 2016-10-12 弗·哈夫曼-拉罗切有限公司 抗病毒化合物
ES2749512T3 (es) 2012-10-02 2020-03-20 Inst Nat Sante Rech Med Derivados de tetrahidroquinolina y su uso como inhibidores de Epac
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
USD976093S1 (en) 2020-09-22 2023-01-24 Milwaukee Electric Tool Corporation Staple collation
CN220302508U (zh) 2020-09-22 2024-01-05 米沃奇电动工具公司 动力式紧固件驱动器及钉排
WO2022094190A2 (en) 2020-10-30 2022-05-05 Milwaukee Electric Tool Corporation Powered fastener driver

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011073A1 (en) 1996-09-10 1998-03-19 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
US6525042B1 (en) 1997-09-30 2003-02-25 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326328A (en) 1885-09-15 Broiler
US326330A (en) 1885-09-15 Harness-support
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
CN1180995A (zh) 1995-04-08 1998-05-06 巴斯福股份公司 防治有害真菌的方法
US6194413B1 (en) * 1995-11-13 2001-02-27 Smithkline Beecham Corporation Hemoregulatory compounds
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
AU1532802A (en) 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
EP1326865B1 (en) 2000-10-12 2009-05-06 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
CN1659143A (zh) 2001-03-01 2005-08-24 盐野义制药株式会社 具有hiv整合酶抑制活性的含氮杂芳基化合物
ATE404537T1 (de) 2002-08-13 2008-08-15 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
EP2059305A2 (en) * 2006-07-26 2009-05-20 Novartis Ag Inhibitors of undecaprenyl pyrophosphate synthase
WO2009140215A2 (en) * 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
UA102336C2 (uk) * 2009-11-10 2013-06-25 Пфайзер Інк. N1-ПІРАЗОЛСПІРОКЕТОНИ ЯК ІНГІБІТОРИ АЦЕТИЛ-СоА-КАРБОКСИЛАЗ
WO2011075630A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011073A1 (en) 1996-09-10 1998-03-19 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
US6525042B1 (en) 1997-09-30 2003-02-25 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives

Also Published As

Publication number Publication date
MY161869A (en) 2017-05-15
IL220427A (en) 2015-04-30
CA2783213A1 (en) 2011-07-07
WO2011080264A1 (en) 2011-07-07
NZ600788A (en) 2013-08-30
EP2345643A1 (en) 2011-07-20
KR20120101563A (ko) 2012-09-13
GEP20156244B (en) 2015-02-10
AU2010338267B2 (en) 2014-03-27
PT2519505E (pt) 2015-09-03
SG181586A1 (en) 2012-07-30
US8729098B2 (en) 2014-05-20
CN102686566A (zh) 2012-09-19
EP2519505A1 (en) 2012-11-07
AU2010338267A2 (en) 2012-07-26
EA201270670A1 (ru) 2013-03-29
JP2013515755A (ja) 2013-05-09
US20120309751A1 (en) 2012-12-06
ECSP12012007A (es) 2012-08-31
HRP20150749T1 (hr) 2015-08-14
DOP2012000186A (es) 2013-01-15
GT201200216A (es) 2014-12-26
MA33829B1 (fr) 2012-12-03
NI201200114A (es) 2013-04-22
PH12012501326A1 (en) 2015-04-01
MX2012007748A (es) 2012-08-03
HUE027220T2 (hu) 2016-10-28
SI2519505T1 (sl) 2015-08-31
JP5808754B2 (ja) 2015-11-10
ZA201204347B (en) 2013-09-25
PE20130179A1 (es) 2013-02-24
PL2519505T3 (pl) 2015-11-30
DK2519505T3 (en) 2015-06-29
CY1116493T1 (el) 2017-03-15
TN2012000320A1 (en) 2013-12-12
AU2010338267A1 (en) 2012-07-19
EP2519505B1 (en) 2015-05-27
EA025563B1 (ru) 2017-01-30
CN105384685A (zh) 2016-03-09
ES2540327T3 (es) 2015-07-09
CA2783213C (en) 2017-09-12
CL2012001757A1 (es) 2013-03-22
RS54096B1 (sr) 2015-10-30
SMT201500182B (it) 2015-09-07
BR112012015728A2 (pt) 2019-09-24
HK1178526A1 (en) 2013-09-13
UA107949C2 (xx) 2015-03-10

Similar Documents

Publication Publication Date Title
JP5808754B2 (ja) 新規な第3級8−ヒドロキシキノリン−7−カルボキサミド誘導体およびその使用
KR101620377B1 (ko) 항진균제로서 사용하기 위한 이차 8-히드록시퀴놀린-7-카르복사미드 유도체
KR20120097407A (ko) 신규한 이차 8-히드록시퀴놀린-7-카르복사미드 유도체
HK1178526B (en) Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
HK1178522B (en) Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
HK1178525B (en) New secondary 8-hydroxyquinoline-7-carboxamide derivatives.

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20191011

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20191011